597 related articles for article (PubMed ID: 33540588)
1. Interplay between ESKAPE Pathogens and Immunity in Skin Infections: An Overview of the Major Determinants of Virulence and Antibiotic Resistance.
Vale de Macedo GHR; Costa GDE; Oliveira ER; Damasceno GV; Mendonça JSP; Silva LDS; Chagas VL; Bazán JMN; Aliança ASDS; Miranda RCM; Zagmignan A; Monteiro AS; Nascimento da Silva LC
Pathogens; 2021 Feb; 10(2):. PubMed ID: 33540588
[TBL] [Abstract][Full Text] [Related]
2. Light Modulates Important Pathogenic Determinants and Virulence in ESKAPE Pathogens Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus.
Tuttobene MR; Pérez JF; Pavesi ES; Perez Mora B; Biancotti D; Cribb P; Altilio M; Müller GL; Gramajo H; Tamagno G; Ramírez MS; Diacovich L; Mussi MA
J Bacteriol; 2021 Feb; 203(5):. PubMed ID: 33288627
[TBL] [Abstract][Full Text] [Related]
3. Cracking the Challenge of Antimicrobial Drug Resistance with CRISPR/Cas9, Nanotechnology and Other Strategies in ESKAPE Pathogens.
Zohra T; Numan M; Ikram A; Salman M; Khan T; Din M; Salman M; Farooq A; Amir A; Ali M
Microorganisms; 2021 Apr; 9(5):. PubMed ID: 33946643
[TBL] [Abstract][Full Text] [Related]
4. Quantifying the Evolutionary Conservation of Genes Encoding Multidrug Efflux Pumps in the ESKAPE Pathogens To Identify Antimicrobial Drug Targets.
Brooks LE; Ul-Hasan S; Chan BK; Sistrom MJ
mSystems; 2018; 3(3):. PubMed ID: 29719870
[TBL] [Abstract][Full Text] [Related]
5. Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.
Ma YX; Wang CY; Li YY; Li J; Wan QQ; Chen JH; Tay FR; Niu LN
Adv Sci (Weinh); 2020 Jan; 7(1):1901872. PubMed ID: 31921562
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level Hospital.
Flores-Paredes W; Luque N; Albornoz R; Rojas N; Espinoza M; Pons MJ; Ruiz J
Infect Chemother; 2021 Sep; 53(3):449-462. PubMed ID: 34508324
[TBL] [Abstract][Full Text] [Related]
7. Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.
Jadimurthy R; Mayegowda SB; Nayak SC; Mohan CD; Rangappa KS
Biotechnol Rep (Amst); 2022 Jun; 34():e00728. PubMed ID: 35686013
[TBL] [Abstract][Full Text] [Related]
8. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
Mulani MS; Kamble EE; Kumkar SN; Tawre MS; Pardesi KR
Front Microbiol; 2019; 10():539. PubMed ID: 30988669
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens.
Santajit S; Indrawattana N
Biomed Res Int; 2016; 2016():2475067. PubMed ID: 27274985
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic and genotypic detection methods for antimicrobial resistance in ESKAPE pathogens (Review).
Muntean MM; Muntean AA; Preda M; Manolescu LSC; Dragomirescu C; Popa MI; Popa GL
Exp Ther Med; 2022 Aug; 24(2):508. PubMed ID: 35837033
[TBL] [Abstract][Full Text] [Related]
11. Coping with the ESKAPE pathogens: Evolving strategies, challenges and future prospects.
Aloke C; Achilonu I
Microb Pathog; 2023 Feb; 175():105963. PubMed ID: 36584930
[TBL] [Abstract][Full Text] [Related]
12. Extent and Resistance Patterns of ESKAPE Pathogens Isolated in Pus Swabs from Hospitalized Patients.
Masoud SS; Kovacevich A; Gangji R; Nyawale H; Nyange M; Ntukula A
Can J Infect Dis Med Microbiol; 2022; 2022():3511306. PubMed ID: 36353409
[TBL] [Abstract][Full Text] [Related]
13. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
[TBL] [Abstract][Full Text] [Related]
14. Tolerance and Resistance of
Ciofu O; Tolker-Nielsen T
Front Microbiol; 2019; 10():913. PubMed ID: 31130925
[No Abstract] [Full Text] [Related]
15. An overview of resistance profiles ESKAPE pathogens from 2010-2015 in a tertiary respiratory center in Romania.
Peneş NO; Muntean AA; Moisoiu A; Muntean MM; Chirca A; Bogdan MA; Popa MI
Rom J Morphol Embryol; 2017; 58(3):909-922. PubMed ID: 29250670
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of medicinal plants against ESKAPE: An update.
Bhatia P; Sharma A; George AJ; Anvitha D; Kumar P; Dwivedi VP; Chandra NS
Heliyon; 2021 Feb; 7(2):e06310. PubMed ID: 33718642
[TBL] [Abstract][Full Text] [Related]
17. Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management.
Sandiumenge A; Rello J
Curr Opin Pulm Med; 2012 May; 18(3):187-93. PubMed ID: 22366995
[TBL] [Abstract][Full Text] [Related]
18. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality.
Ye QF; Zhao J; Wan QQ; Qiao BB; Zhou JD
Transpl Infect Dis; 2014 Oct; 16(5):767-74. PubMed ID: 25124187
[TBL] [Abstract][Full Text] [Related]
19. Nonribosomal peptide synthetase biosynthetic clusters of ESKAPE pathogens.
Gulick AM
Nat Prod Rep; 2017 Aug; 34(8):981-1009. PubMed ID: 28642945
[TBL] [Abstract][Full Text] [Related]
20. Revisiting ESKAPE Pathogens: virulence, resistance, and combating strategies focusing on quorum sensing.
Venkateswaran P; Vasudevan S; David H; Shaktivel A; Shanmugam K; Neelakantan P; Solomon AP
Front Cell Infect Microbiol; 2023; 13():1159798. PubMed ID: 37457962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
